Bliss GVS Pharma Limited Q1, Q2, Q3, Q4, FY 2016-17, FY 2015-16 Standalone / Consolidated Results, Revenues, Net Profit, Tax, EPS, Live Chart …
Bliss GVS Pharma Limited Company Profile :
Bliss GVS Pharma Limited is an Indian company engaged in developing, manufacturing and marketing pharmaceutical formulations.
The Company offers a range of suppositories and pessaries in various therapeutic categories, including women’s health, which consists of anti-fungal, anti-bacterial, contraceptive and lubricants; gastro-intestinal basket, which consists of anti-hemorrhoid, laxatives, anti-inflammatory and anti-emetic, and anti-malarial, which consists of artesunate suppositories.
BSE Code : 506197
NSE Symbol : BLISSGVS
ISIN No. : INE416D01022
Industry : Pharmaceuticals
Face Value : Rs. 1.00
If you are an investor who has shares of Bliss GVS Pharma or you are an stock market analyst then i am sure you might for Quarterly Results of Bliss GVS Pharma.
In this article you will find Q1, Q2, Q3, Q4 and FY 2016-17 Results of Bliss GVS Pharma. That’s not all, you can compare those results with previous year i.e., FY 2015-16 Results of v.
Bliss GVS Pharma Q1 Results 2016-17 :
Bliss GVS Pharma will announce its Q1 FY 2016-17 Results in the month of July 2016. We will update the table below once the results are announced.
|(Values in Cr.)||Q1 Standalone||Q1 Consolidated|
Bliss GVS Pharma will announce its Q2 FY 2016-17 Results in the month of October 2016.
Bliss GVS Pharma will announce its Q3 FY 2016-17 Results in the month of January 2017.
Bliss GVS Pharma will announce its Q4 FY 2016-17 Results in the month of April 2017.
Bliss GVS Pharma will announce its FY 2016-17 Results in the month of April 2017.
Note : We will update the results table above as and when results are announced. Visit again.
Bliss GVS Pharma Previous Year’s Results (FY 2015-16) :
|(Values in Cr.)||Standalone||Consolidated|
Note : If you like this information about Bliss GVS Pharma Quarterly Results, then please share it with all your friends, relatives and other investors on Facebook, Twitter, WhatsApp, Email, etc.